Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Leukemia

Free Subscription 27.04.2026 1 Am J Clin Pathol 2 Ann Hematol 7 Blood 1 BMC Cancer 1 Bone Marrow Transplant 1 Cancer 1 Cancer Lett 1 Eur J Haematol 1 Exp Hematol 1 Int J Hematol 2 J Clin Oncol 1 J Virol 2 Leuk Lymphoma 5 Leukemia 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Pathol

1. HAO L, Xu T, Yu Y, Huang Q, et al
   S1PR3 expression independently predicts the cumulative incidence of relapse in adult B-cell acute lymphoblastic leukemia: a single-center retrospective analysis.
   Am J Clin Pathol. 2026;165:aqag026.
   PubMed         Abstract available
   
   

   
   Ann Hematol

2. PARK S, Kim SA, Kim S, Kim SY, et al
   Distinct immunophenotypic and clinical features of TP53-mutated acute myeloid leukemia: high CD34/CD41 expression and lower leukocyte counts.
   Ann Hematol. 2026;105:259.
   PubMed         Abstract available
   
   
3. BRECCIA M, Giai V, Rosso T, Pregno P, et al
   Age and gender effects on molecular responses in chronic myeloid leukemia patients by first-line treatment: an Italian CML network cohort study.
   Ann Hematol. 2026;105:252.
   PubMed         Abstract available
   
   

   
   Blood

4. 
   Carter BZ, Mak PY, Ayoub E, et al. Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemia. Blood. 2025;146(21):2574-2588.
   Blood. 2026;147:2020.
   PubMed        
   
   
5. WANG W, Fang H
   NPM1-mutated acute myeloid leukemia with a hybrid granulocytic and monocytic phenotype.
   Blood. 2026;147:2019.
   PubMed        
   
   
6. LI Y, Shao H
   B-lymphoblastic leukemia with synchronous KMT2A::TXNRD1 and IGH::CEBPD rearrangements.
   Blood. 2026;147:2018.
   PubMed        
   
   
7. WU CJ, Caligaris-Cappio F, Chiorazzi N, Gribben JG, et al
   Unfinished Business in Chronic Lymphocytic Leukemia: Translational and Clinical Priorities for a Cure.
   Blood. 2026 Apr 22:blood.2025032393. doi: 10.1182/blood.2025032393.
   PubMed         Abstract available
   
   
8. SRINAGESH HK, Gupta V, Zhang A, Grunwald M, et al
   Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL.
   Blood. 2026;147:2011-2017.
   PubMed         Abstract available
   
   
9. MUSHTAQ MU, DiPersio JF, Azzi J, Cooper BW, et al
   A phase 1/2 study of donor-derived anti-CD33 CAR T-cell therapy (VCAR33) for relapsed/refractory AML after allogeneic HCT.
   Blood. 2026;147:1914-1927.
   PubMed         Abstract available
   
   
10. SEKRECKI M, Sekrecka A, Lattupally RR, Le K, et al
    Oncogenic SF3B1 mutations alter the splicing of mRNA noncoding regions to induce a novel therapeutic vulnerability.
    Blood. 2026;147:1941-1957.
    PubMed         Abstract available
    
    

    
    BMC Cancer

11. TANBOUR R, Ishtayeh M, Alhindi MK, Amer R, et al
    Clinical characteristics and treatment outcomes of adult acute promyelocytic leukemia in the West Bank of Palestine: a single center retrospective study.
    BMC Cancer. 2026 Apr 20. doi: 10.1186/s12885-026-16031.
    PubMed        
    
    

    
    Bone Marrow Transplant

12. ANDREOZZI F, Galimard JE, Maertens J, Aljurf M, et al
    Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP).
    Bone Marrow Transplant. 2026 Apr 22. doi: 10.1038/s41409-026-02857.
    PubMed         Abstract available
    
    

    
    Cancer

13. LAWRENCE L
    Studies continue to individualize treatment strategies for patients with CLL and SLL: Trial data show that first-line pirtobrutinib significantly improves progression-free survival in patients with previously untreated chronic or small lymphocytic leu
    Cancer. 2026;132:e70356.
    PubMed        
    
    

    
    Cancer Lett

14. MA R, Zhang J, Zhang MX, Li Y, et al
    Survival benefit of allogeneic HSCT in CMML patients during the molecular stratification era.
    Cancer Lett. 2026;649:218489.
    PubMed         Abstract available
    
    

    
    Eur J Haematol

15. SONG L, Wei X, Zhai Z, Wang A, et al
    Phase I/II Trial of the FLT3 Kinase Inhibitor XY0206 in Patients With Relapsed/Refractory Acute Myeloid Leukemia.
    Eur J Haematol. 2026 Apr 21. doi: 10.1111/ejh.70164.
    PubMed         Abstract available
    
    

    
    Exp Hematol

16. ISOBE T, Meggendorfer M, Wolf S, Oellerich T, et al
    Stem11 score: towards rapid clinical prognostication for acute myeloid leukemia.
    Exp Hematol. 2026 Apr 17:105441. doi: 10.1016/j.exphem.2026.105441.
    PubMed         Abstract available
    
    

    
    Int J Hematol

17. YOKOYAMA S, Onozawa M, Kimura H, Ara T, et al
    Philadelphia chromosome-negative but BCR::ABL1-positive acute lymphoblastic leukemia: a real-world multicenter cohort study.
    Int J Hematol. 2026 Apr 22. doi: 10.1007/s12185-026-04212.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

18. WIERDA WG, Leow CC, Ruppert AS, Bian Y, et al
    Reply to: How to Interpret the Results in a Noninferiority Randomized Trial in Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2026 Apr 20:JCO2600304. doi: 10.1200/JCO-26-00304.
    PubMed        
    
    
19. LEVY V, Chevret S
    How to Interpret the Results in a Noninferiority Randomized Trial in Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2026 Apr 20:JCO2503114. doi: 10.1200/JCO-25-03114.
    PubMed        
    
    

    
    J Virol

20. SARKER MAK, Polakowski N, Sagasti C, Hoang K, et al
    Myoferlin contributes to invasiveness of human T-cell leukemia virus type 1-infected T cells.
    J Virol. 2026 Apr 21:e0026426. doi: 10.1128/jvi.00264.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

21. MARCINEK A, Huber S, Hutter S, Meggendorfer M, et al
    Defined genetic abnormalities shape the clonal hierarchy in acute myeloid leukemia as founding events.
    Leuk Lymphoma. 2026 Apr 21:1-4. doi: 10.1080/10428194.2026.2659222.
    PubMed        
    
    
22. LEVY YURKOVSKI I, Schiff E, Attias S, Sharf G, et al
    Use of dietary and herbal supplements and communication with hematologists regarding such use among patients with CLL: a national survey.
    Leuk Lymphoma. 2026;67:1080-1087.
    PubMed         Abstract available
    
    

    
    Leukemia

23. HOCHHAUS A, le Coutre P, Milojkovic D, Kim DDH, et al
    ASC4OPT: asciminib treatment optimization study in patients with chronic myeloid leukemia in chronic phase previously treated with two or more tyrosine kinase inhibitors.
    Leukemia. 2026 Apr 23. doi: 10.1038/s41375-026-02965.
    PubMed         Abstract available
    
    
24. DREWES C, Lopez C, Okeke N, Jebaraj B, et al
    The spectrum of immunoglobulin heavy chain enhancer hijacking in chronic lymphocytic leukemia.
    Leukemia. 2026 Apr 23. doi: 10.1038/s41375-026-02902.
    PubMed         Abstract available
    
    
25. SABERI M, Delfi O, Hall CJ, Madola DWKK, et al
    A transgenic zebrafish leukemia model driven by KMT2A::MLLT3 (MLL-AF9).
    Leukemia. 2026 Apr 22. doi: 10.1038/s41375-026-02953.
    PubMed        
    
    
26. HOUTMAN AH, Arfeuille C, Strullu M, Baruchel A, et al
    Genomic fusion breakpoints for DNA-based measurable residual disease monitoring in pediatric acute lymphoblastic leukemia.
    Leukemia. 2026 Apr 21. doi: 10.1038/s41375-026-02958.
    PubMed         Abstract available
    
    
27. ZHANG L, Guo W, Fu YH, Wu D, et al
    HDAC8 inhibition targets STAT3-MYC axis and synergizes with Venetoclax in KMT2A-rearranged acute myeloid leukemia.
    Leukemia. 2026 Apr 21. doi: 10.1038/s41375-026-02950.
    PubMed         Abstract available
    
    

    
    PLoS One

28. DAVID J, Walsh A, Seow KS, Walsh E, et al
    Upregulation of CD1d and ULBP3 on B cells from healthy donors and chronic lymphocytic leukaemia patients does not prime them for killing by gammadelta T cells.
    PLoS One. 2026;21:e0346684.
    PubMed         Abstract available
    
    
29. RIVERA-ORCOAPAZA C, Rosales-Rimache J
    Diagnostic performance of DNA index for detection of high hyperdiploidy in childhood B-cell acute lymphoblastic leukemia.
    PLoS One. 2026;21:e0347201.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum